What is LOPJLB’s current signal on ARQT?

LOPJLB’s latest quantitative signal on Arcutis Biotherapeutics, Inc. (ARQT) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is ARQT in?

Arcutis Biotherapeutics, Inc. (ARQT) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is Arcutis Biotherapeutics, Inc. based / listed?

Arcutis Biotherapeutics, Inc. is based in US, listed on NASDAQ.

Arcutis Biotherapeutics, Inc. (ARQT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$24.49+1.32%Close

SELLRECOVERY · day 95

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $3.1B
Beta: 1.58
P/E (TTM): 108.33

Short % float: 16.75%
Days to cover: 8.5
SI change: +11.5%

1W: -3.16%
1M: +2.73%

vs SPY 1W: -4.72%
vs SPY 1M: +0.96%

Industry peers

FMP comparable companies · ranked by market cap

ACRSSELLAclaris Therapeutics, Inc.$529MCRISISQ 9$3.79+11.47%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded…

Employees: 354
Headquarters: US
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 125.1M
Float: 88.1%

arcutis.com ↗

Key executives

Todd Franklin Watanabe — President, Chief Executive Officer & Director

L. Todd Edwards — Executive Vice President & Chief Commercial Officer

Patrick E. Burnett — Executive Vice President & Chief Medical Officer

SEC filings

EDGAR · CIK 17873060 · ARQT

Analyst consensus

Buy

Bullish1083.3%

Neutral216.7%

Bearish00.0%

L $38.00Avg $38.33H $39.00

Target$38.33+56.51%

Last$24.49

Key stats

Industry peers

Prediction markets

Company news